Form 4: Nuvve CEO Sells 326,000 Shares in Planned Transactions
Insider Transaction Report
Nuvve Holding Corp. CEO Gregory Poilasne reported the sale of 326,000 shares of common stock over three transactions in late November and early December 2025, executed under a Rule 10b5-1 plan.
Summary
- Gregory Poilasne, CEO and Director of Nuvve Holding Corp. (NVVE), reported the sale of 326,000 shares of common stock.
- The sales occurred over three separate transactions between November 26, 2025, and December 1, 2025.
- These transactions were conducted pursuant to a Rule 10b5-1 pre-arranged trading plan.
- On November 26, 2025, 100,000 shares were sold at a weighted average price of $0.27 per share, with prices ranging from $0.25 to $0.29.
- On November 28, 2025, another 100,000 shares were sold at a weighted average price of $0.24 per share, with prices ranging from $0.22 to $0.25.
- On December 1, 2025, 126,000 shares were sold at a weighted average price of $0.18 per share, with prices ranging from $0.17 to $0.20.
- Following these transactions, Poilasne beneficially owns 1,330,474.78 shares of Nuvve Holding Corp. common stock.
Sentiment
Score: 3
Explanation: The sentiment is negative due to significant insider selling by the CEO, particularly as the average sale price declined across the transactions. While executed under a 10b5-1 plan, the sheer volume and decreasing price point can be perceived as a lack of confidence or a need for liquidity, which typically weighs on investor sentiment.
Positives
- The sales were executed under a Rule 10b5-1 plan, indicating they were pre-scheduled and not necessarily a reaction to recent company performance or news.
Negatives
- The CEO sold a significant number of shares (326,000) over a short period.
- The average sale price decreased across the three transactions, from $0.27 to $0.24 to $0.18, potentially indicating a declining stock price trend during the sale period.
- Insider selling, even under a 10b5-1 plan, can sometimes be perceived negatively by the market as it reduces the insider's direct stake in the company.
Risks
- Potential negative market perception due to significant insider selling, which could put downward pressure on the stock price.
- The declining average sale price across the transactions suggests potential volatility or a downward trend in the company's stock value during that period.
Future Outlook
N/A
Industry Context
N/A
Stakeholder Impact
- Shareholders: May interpret the significant insider selling as a negative signal, potentially leading to downward pressure on the stock price.
- Employees: No direct impact mentioned, but a declining stock price could affect morale or equity compensation value.
Key Dates
| Date | Description |
|---|---|
| 11/26/2025 | Transaction date for the sale of 100,000 shares of common stock. |
| 11/28/2025 | Transaction date for the sale of 100,000 shares of common stock. |
| 12/01/2025 | Transaction date for the sale of 126,000 shares of common stock and signature date of the filing. |
Recommendation
sellThe significant insider selling by the CEO, Gregory Poilasne, of 326,000 shares over a short period, coupled with a declining average sale price across the transactions ($0.27 down to $0.18), suggests a lack of confidence from a key executive or a need for personal liquidity. While executed under a Rule 10b5-1 plan, the volume and price trend are strong negative signals that could indicate further downward pressure on the stock. Investors should consider reducing exposure.
Keywords
Nuvve Holding Corp., NVVE, Gregory Poilasne, Insider Selling, Form 4, Stock Sale, CEO, Rule 10b5-1, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.